FDA Approved: BUMETANIDE — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)

View source ↗

Summary

FDA approved a supplemental application for bumetanide from Qilu Pharmaceutical Co., Ltd., authorizing the generic product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Liver Cirrhosis
• Nephrotic Syndrome
• Renal Disease

Drugs mentioned

• BUMETANIDE (bumetanide)

Snippet

SUPPL AP for BUMETANIDE (BUMETANIDE)